主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XTLB
#8937
XTL Biopharmaceuticals Ltd. American Depositary Shares
0.600
0
USD
-4.76%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-4.76%
每月变动
-33.18%
6个月变化
-33.18%
年变化
-33.18%
前一天收盘价
0.630
0
Open
0.600
0
Bid
0.600
0
Ask
0.603
0
Low
0.600
0
High
0.600
0
交易量
1
市场
股票
医疗保健
XTLB
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
128.55 M
136.23 M
136.23 M
136.23 M
220.35 M
629.03 M
Valuation ratios
Enterprise value
385.88 M
374.38 M
169.54 M
131.75 M
446.01 M
1.13 B
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.07
0.32
0.73
0.12
—
Return on equity %
0.13
0.08
0.34
0.8
0.19
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
100
0.67
—
Operating margin %
—
—
—
1 865.85
481.6
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
4 346.34
227.72
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.05
9.03
6.81
4.98
0.61
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
0.01
0.08
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
新闻
XTL生物制药公司收到纳斯达克摘牌通知
XTL Biopharmaceuticals faces Nasdaq delisting notice
XTL生物制药因纳斯达克摘牌通知股价下跌
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice
XTL生物制药股东批准增加股本及私募配售
XTL Biopharmaceuticals shareholders approve share capital increase and private placement
XTL Biopharmaceuticals子公司Social Proxy因法院命令进入清算程序
XTL Biopharmaceuticals subsidiary Social Proxy enters liquidation following court order
XTL生物制药推进NeuroNOS收购并计划私募融资
XTL Biopharmaceuticals moves forward with NeuroNOS acquisition and plans private placement
XTL生物制药子公司向以色列法院申请破产程序
XTL Biopharmaceuticals subsidiary files for insolvency in Israeli court